← Leaderboards
Zhou Wang
University Of Pittsburgh At Pittsburgh
$17,521,825
Attributed
$19,824,929
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,897,099 · 21
By mechanism
R01$10,866,919 · 8
U54$9,790,148 · 3
R37$2,499,864 · 1
P50$1,452,899 · 2
T32$1,141,751 · 1
P20$793,308 · 2
Top collaborators
- Joel B Nelson4 shared
- Peter X Wipf4 shared
- Naoki Yoshimura3 shared
- Shivendra Singh1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Bradley K Taylor$17,950,936
- Joseph T Newsome$4,616,639
- Dong Xiao$963,746
- Joel B Nelson$928,618
- Rebecca J Leeman$133,834
Others in their field
Top investigators on “Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$257,543,614
- Charles A Coltman · Southwest Oncology Group$181,133,593
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Larry Arthur$62,719,328
- William J. Blot · Vanderbilt University$62,640,427
- Walter John Curran · Thomas Jefferson University$60,981,384
Research focus
ProstateAndrogensSpecimenSuccessLeadMolecularResearch PersonnelAffectBenign Prostatic HypertrophyProgramsUniversitiesGenesMalignant Neoplasm Of ProstateEpithelial CellsFoundationsPathogenesisEpithelialLower Urinary Tract SymptomsGene ExpressionNovel StrategiesProstaticInsightPreventionDown-Regulation
Grant awards (83)
Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract Dysfunction$475,399
R01 · FY2025 · DK · contact PI
Targeting androgen receptor nuclear localization in prostate cancer$374,450
R01 · FY2025 · CA · contact PI
Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract Dysfunction$511,124
R01 · FY2024 · DK · contact PI
Targeting androgen receptor nuclear localization in prostate cancer$355,729
R01 · FY2024 · CA · contact PI
Structural and functional analysis of a novel class of androgen receptor antagonists$100,659
R21 · FY2024 · CA · contact PI
Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract Dysfunction$536,617
R01 · FY2023 · DK · contact PI
Targeting androgen receptor nuclear localization in prostate cancer$366,962
R01 · FY2023 · CA · contact PI
Structural and functional analysis of a novel class of androgen receptor antagonists$149,651
R21 · FY2023 · CA · contact PI
Targeting androgen receptor nuclear localization in prostate cancer$374,450
R01 · FY2022 · CA · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$1,199,999
U54 · FY2020 · DK · contact PI
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program$433,200
U54 · FY2020 · DK · contact PI
Luminal epithelial junctions, polarity, and permeability in BPH pathogenesis$218,675
U54 · FY2020 · DK · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$1,200,000
U54 · FY2019 · DK · contact PI
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program$346,615
U54 · FY2019 · DK · contact PI
Luminal epithelial junctions, polarity, and permeability in BPH pathogenesis$241,456
U54 · FY2019 · DK · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$1,200,000
U54 · FY2018 · DK · contact PI
Roles of EAF2 in androgen action in the prostate$371,525
R01 · FY2018 · CA · contact PI
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program$344,210
U54 · FY2018 · DK · contact PI
Luminal epithelial junctions, polarity, and permeability in BPH pathogenesis$244,002
U54 · FY2018 · DK · contact PI
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program$100,000
U54 · FY2018 · DK · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$100,000
U54 · FY2018 · DK · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$1,200,000
U54 · FY2017 · DK · contact PI
Roles of EAF2 in androgen action in the prostate$371,525
R01 · FY2017 · CA · contact PI
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program$341,918
U54 · FY2017 · DK · contact PI
Luminal epithelial junctions, polarity, and permeability in BPH pathogenesis$246,429
U54 · FY2017 · DK · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$100,000
U54 · FY2017 · DK · contact PI
University of Pittsburgh O'Brien Cooperative Research Center Program$1,525,532
U54 · FY2016 · DK · contact PI
The University of Pittsburgh O'Brien Urology Cooperative Research Center Program$431,900
U54 · FY2016 · DK · contact PI
Roles of EAF2 in androgen action in the prostate$371,525
R01 · FY2016 · CA · contact PI
Luminal epithelial junctions, polarity, and permeability in BPH pathogenesis$316,212
U54 · FY2016 · DK · contact PI
Luminal Epithelial Junctions, Polarity, and Permeability in BPH Pathogenesis$92,400
R56 · FY2016 · DK · contact PI
Roles of EAF2 in androgen action in the prostate$371,525
R01 · FY2015 · CA · contact PI
Roles of EAF2 in androgen action in the prostate$370,620
R01 · FY2014 · CA · contact PI
Mechanistic Studies on Prostate Cancer Prevention by Gugulipid$309,964
R01 · FY2014 · CA · contact PI
University of Pittsburgh Urologic Training Program for Scientists$266,780
T32 · FY2014 · DK · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$363,009
R37 · FY2013 · DK · contact PI
Androgen signaling in benign prostatic hyperplasia (BPH)$300,326
R01 · FY2013 · DK · contact PI
University of Pittsburgh Urologic Training Program for Scientists$252,084
T32 · FY2013 · DK · contact PI
P-1: 5A-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Pros$250,116
P50 · FY2013 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$376,175
R37 · FY2012 · DK · contact PI
Androgen signaling in benign prostatic hyperplasia (BPH)$311,219
R01 · FY2012 · DK · contact PI
Molecular signatures associated with prostatic inflammation in rodent models.$246,669
P20 · FY2012 · DK · contact PI
Molecular signatures associated with prostatic inflammation in rodent models.$246,669
P20 · FY2012 · DK · contact PI
P-1: 5A-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Pros$245,200
P50 · FY2012 · CA · contact PI
University of Pittsburgh Urologic Training Program for Scientists$211,678
T32 · FY2012 · DK · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$376,175
R37 · FY2011 · DK · contact PI
P-1: 5A-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Pros$325,493
P50 · FY2011 · CA · contact PI
Androgen signaling in benign prostatic hyperplasia (BPH)$311,219
R01 · FY2011 · DK · contact PI
Role of Eaf family proteins in prostate carcinogenesis$273,686
R01 · FY2011 · CA · contact PI
University of Pittsburgh Urologic Training Program for Scientists$171,452
T32 · FY2011 · DK · contact PI
University of Pittsburgh Planning Center for Benign Prostate Hyperplasia Research$149,985
P20 · FY2011 · DK · contact PI
2011 AUA/SBUR Basic Sciences Symposium$9,500
U13 · FY2011 · DK · contact PI
Androgen signaling in benign prostatic hyperplasia (BPH)$378,750
R01 · FY2010 · DK · contact PI
P-1: 5A-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Pros$311,914
P50 · FY2010 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$286,788
R37 · FY2010 · DK · contact PI
Role of Eaf family proteins in prostate carcinogenesis$282,150
R01 · FY2010 · CA · contact PI
University of Pittsburgh Urologic Training Program for Scientists$239,757
T32 · FY2010 · DK · contact PI
University of Pittsburgh Planning Center for Benign Prostate Hyperplasia Research$149,985
P20 · FY2010 · DK · contact PI
5-Alpha-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Prostat$320,176
P50 · FY2009 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$289,685
R37 · FY2009 · DK · contact PI
Role of Eaf family proteins in prostate carcinogenesis$282,150
R01 · FY2009 · CA · contact PI
AR intracellular trafficking in prostate cancer$247,682
R01 · FY2009 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$289,685
R37 · FY2008 · DK · contact PI
Role of Eaf family proteins in prostate carcinogenesis$282,150
R01 · FY2008 · CA · contact PI
AR intracellular trafficking in prostate cancer$247,682
R01 · FY2008 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$295,597
R37 · FY2007 · DK · contact PI
Role of Eaf family proteins in prostate carcinogenesis$282,150
R01 · FY2007 · CA · contact PI
AR intracellular trafficking in prostate cancer$247,682
R01 · FY2007 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$222,750
R37 · FY2006 · DK · contact PI
AR intracellular trafficking in prostate cancer$127,540
R01 · FY2006 · CA · contact PI
AR intracellular trafficking in prostate cancer$127,540
R01 · FY2006 · CA · contact PI
Role of U19/Eaf2 in androgen-dependent prostate homeostasis$82,225
R01 · FY2006 · DK · contact PI
ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE$294,000
R01 · FY2005 · DK
AR intracellular trafficking in prostate cancer$261,219
R01 · FY2005 · CA
ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE$294,000
R01 · FY2004 · DK
ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE$294,000
R01 · FY2003 · DK
ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE$294,000
R01 · FY2002 · DK
ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE$40,000
R01 · FY2002 · DK
SUPPRESSIVE ROLE OF ANDROGEN RESPONSE GENE CALRETICULIN IN PROSTATE CANCER$0
P50 · FY2002 · CA
ROLE OF A NOVEL ANDROGEN-RESPONSE GENE IN PROSTATE$257,250
R01 · FY2001 · DK
SUPPRESSIVE ROLE OF ANDROGEN RESPONSE GENE CALRETICULIN IN PROSTATE CANCER$0
P50 · FY2001 · CA
SUPPRESSIVE ROLE OF ANDROGEN RESPONSE GENE CALRETICULIN$0
R25 · FY2001 · CA
ANDROGEN REGULATED GENE EXPRESSION IN THE PROSTATE$186,884
R01 · FY2000 · DK